Randomized Controlled Trial to Compare Two Anti-scorpion Serums

Scorpion Sting Clinical Trial

Official title: Randomized Controlled Trial to Evaluate Efficiency and Safety of the Polyvalent Antiscorpion Serum of Birmex Versus Other Commercial Serum

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum

Clinical Trial Description

We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem.

This is a randomized clinical trial, which included 120 subjects of both sexes aged 15 and 60 years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients received antiscorpion serum of Birmex and 60 patients receive other commercial serum. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Scorpion Sting
• Scorpion Stings

• NCT number: NCT00739440
• Study type: Interventional
• Source: Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
• Status: Completed
• Phase: Phase 4
• Start date: August 2008
• Completion date: November 2008